Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
Business Wire2d
0.45
RioCan Real Estate Investment Trust (“RioCan" or the "Trust”) (TSX: REI.UN) announced today its financial results for the ...
Starmer: I am ready and willing to put British troops in Ukraine
Sir Keir Starmer has announced he is “ready and willing” to put British troops on the ground in Ukraine to enforce any peace ...
This is how Ukraine’s war ends. But Trump’s plan for what comes next is even more radical
Negotiations aimed at freezing the conflict could finally put an end to the fighting – and lay the foundation for a new world ...